| ²é¿´: 352 | »Ø¸´: 3 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| ¡¾Óн±½»Á÷¡¿»ý¼«»Ø¸´±¾Ìû×Ó£¬²ÎÓë½»Á÷£¬¾ÍÓлú»á·ÖµÃ×÷Õß ÎÒÊǻδΠµÄ 10 ¸ö½ð±Ò | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
¹òÇóµ°°×øÒÖÖÆ¼Á£¡
|
|||
| Çë½Ì£ºÎÒÓÐÒ»¸ö»îÐÔλµãΪËÕ°±ËáµÄø£¨¦Ã-¹È°±õ£×ªëÄø£©£¬ÇëÎÊÓÃʲôÒÖÖÆ¼Á¿ÉÒÔÒÖÖÆÆä»îÐÔ£¿×îºÃ¸½ÓÐÏà¹ØÎÄÏ×£¬Ð»Ð»£¡£¡ |
» ²ÂÄãϲ»¶
¸´ÊÔµ÷¼Á£¬Ò»Ö¾Ô¸ÄÏÅ©083200ʳƷ¿ÆÑ§Ó빤³Ì
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸ÄÏʦ´ó0703»¯Ñ§ 275Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
0703»¯Ñ§
ÒѾÓÐ3È˻ظ´
308Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
289Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Çóµ÷¼ÁÍÆ¼ö ²ÄÁÏ 304
ÒѾÓÐ12È˻ظ´
²ÄÁÏÓ뻯¹¤085600£¬×Ü·Ö304£¬±¾¿ÆÓÐÁ½Æªsci²ÎÓ룬Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
¿¼Ñл¯Ñ§308·ÖÇóµ÷¼Á
ÒѾÓÐ12È˻ظ´
085600£¬²ÄÁÏÓ뻯¹¤321·Ö£¬Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
4Â¥2008-09-18 23:38:47
|
ÎÒÓùýAcivicin£¬²»¿ÉÄæÒÖÖÆ¼Á£¬Õâ¸ö¶«¶«£¬»ù±¾ÐÅÏ¢ÈçÏ£¬ÎÒÊÇ´ÓÂòµÄÕâ¸ö¶«Î÷µÄ˵Ã÷ÊéÉÏÕÒµ½µÄ¡£ Acivicin (AT-125, U-42126) 99%, MW=178.6 [42228-92-2] Storage: -20¡ãC Irreversible inhibitor of ¦Ã-glutamyl transpeptidase (GGT) ID50 = 0.54 mM. Inhibits the enzymatic conversion of leukotriene C4 to leukotriene D4.1,2 Displays antitumor3 and anti-metastatic activity4. Blocks H. Pylori GGT-induced T-cell inhibition5. Inhibits bioactivation/release of nitric oxide from GSNO6. ÎÄÏ×ÈçÏ£º http://www.ncbi.nlm.nih.gov/pubmed/9178957 The gamma-glutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture |
2Â¥2008-09-17 19:02:35
3Â¥2008-09-18 13:42:39














»Ø¸´´ËÂ¥